Biological Background and Function of ATP8A2

ATP8A2 (ATPase Phospholipid Transporting 8A2) is a member of the P4-ATPase subfamily, a group of evolutionarily conserved flippases responsible for maintaining phospholipid asymmetry across cellular membranes. In healthy eukaryotic cells, the plasma membrane bilayer is asymmetric: phosphatidylcholine (PC) and sphingomyelin predominate in the outer leaflet, while phosphatidylserine (PS) and phosphatidylethanolamine (PE) are concentrated in the inner, cytoplasmic leaflet. This asymmetry is actively maintained by flippases such as ATP8A2.

ATP8A2 forms a functional heterodimer with its accessory subunit CDC50A (TMEM30A), which is essential for the correct folding, trafficking, and activity of the transporter complex. Together, they catalyze the ATP-hydrolysis-driven translocation of PS and PE from the exoplasmic to the cytoplasmic leaflet. Loss of this asymmetry—manifested as PS exposure on the cell surface—serves as a key signal in apoptosis, platelet activation, and immune recognition.

ATP8A2 is most highly expressed in the brain, retina, and testes. Its neurological importance is underscored by findings that loss-of-function mutations in the ATP8A2 gene cause a rare autosomal recessive disorder characterized by cerebellar ataxia, intellectual disability, and disequilibrium (CAMRQ4). Research using recombinant ATP8A2 protein has helped elucidate the molecular mechanisms underlying phospholipid transport and its dysregulation in human disease.

Biochemical Properties of Recombinant Human ATP8A2 Protein

Recombinant Human ATP8A2 Protein is typically produced in mammalian or insect cell expression systems to ensure proper post-translational modifications, including glycosylation and disulfide bond formation, which are critical for the native conformation and enzymatic activity of this multi-pass transmembrane protein. The recombinant protein is generally supplied with an affinity purification tag (such as His or GST) to facilitate downstream purification and detection.

As a P-type ATPase, ATP8A2 undergoes a series of conformational transitions during its catalytic cycle—E1, E1P, E2P, and E2 states—coupled to phospholipid transport and ATP hydrolysis. The protein requires Mg²⁺ ions as a cofactor for ATPase activity. Its activity can be quantitatively assessed using inorganic phosphate release assays (e.g., malachite green colorimetric assay) or by monitoring the fluorescent lipid analogue translocation in reconstituted proteoliposome systems.

Researchers should note that full enzymatic activity of ATP8A2 depends on co-expression or reconstitution with its beta-subunit CDC50A. Preparations supplied as the heterodimeric complex are recommended for activity-dependent assays, while the single-subunit recombinant protein is suitable for antibody generation, binding studies, and structural research.

Research Applications

Recombinant Human ATP8A2 Protein supports a diverse range of research applications in cell biology, neuroscience, and biochemistry:

• Enzyme Activity Assays: Measuring ATPase activity in the presence of phospholipid substrates to characterize flippase kinetics and screen for small-molecule modulators or inhibitors.
• Antibody Production and Validation: Used as an immunogen or positive control antigen to raise and validate anti-ATP8A2 antibodies for Western blot, immunohistochemistry, and ELISA applications.
• Protein–Protein Interaction Studies: Identifying novel binding partners of ATP8A2 or its subunit CDC50A using pull-down assays, co-immunoprecipitation, or surface plasmon resonance (SPR).
• Structural Biology: Providing purified protein for cryo-electron microscopy (cryo-EM) or X-ray crystallography studies aimed at resolving ATP8A2 conformational states during the transport cycle.
• Drug Discovery: Screening compound libraries for modulators of phospholipid flippase activity relevant to neurological diseases and conditions associated with disrupted membrane asymmetry.
• Cell-Free and Reconstitution Systems: Reconstituting ATP8A2 into proteoliposomes to study lipid transport in a defined, controlled biochemical environment.

These applications make Recombinant Human ATP8A2 Protein an indispensable reagent for laboratories investigating membrane biology, neurodegeneration, and rare genetic disorders.

Storage, Handling, and Quality Considerations

Proper storage and handling of Recombinant Human ATP8A2 Protein are essential to preserve its structural integrity and functional activity. As a multi-pass transmembrane protein, ATP8A2 is particularly sensitive to detergent conditions, freeze-thaw cycles, and temperature fluctuations.

Storage: The recombinant protein should be stored at −80 °C for long-term preservation. Aliquot upon receipt to avoid repeated freeze-thaw cycles, which can cause aggregation and loss of activity. Short-term storage at 4 °C is acceptable for up to one week if a stabilizing buffer containing glycerol and a mild non-ionic detergent (e.g., DDM or digitonin) is used.

Reconstitution and Dilution: Reconstitute lyophilized protein according to the manufacturer's instructions using the recommended buffer. Avoid vigorous vortexing; gently pipette to mix. Centrifuge briefly before use to pellet any aggregates.

Quality Assurance: Each lot of Recombinant Human ATP8A2 Protein from Aladdin Scientific is subject to SDS-PAGE purity analysis and, where applicable, functional verification by ATPase activity assay. Researchers are encouraged to request a Certificate of Analysis (CoA) to confirm lot-specific purity, concentration, and activity data before use.